Compile Data Set for Download or QSAR
Report error Found 262 Enz. Inhib. hit(s) with all data for entry = 11555
TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626369(US11787780, Example 4 | (S)—N-(1-(1-(4-fluoro...)
Affinity DataIC50: 2nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626566(US11787780, Example 266 | US11787780, Example 296 ...)
Affinity DataIC50: 2.90nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626461(US11787780, Example 107)
Affinity DataIC50: 3nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626465(US11787780, Example 111)
Affinity DataIC50: 3nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626472(US11787780, Example 120)
Affinity DataIC50: 3nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626597(US11787780, Example 305)
Affinity DataIC50: 3nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626603(US11787780, Example 311)
Affinity DataIC50: 3nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626590(US11787780, Example 298)
Affinity DataIC50: 3.60nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626483(US11787780, Example 131)
Affinity DataIC50: 4nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626586(US11787780, Example 294)
Affinity DataIC50: 4nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626554(US11787780, Example 250 | US11787780, Example 249)
Affinity DataIC50: 4.10nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626595(US11787780, Example 303)
Affinity DataIC50: 4.40nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626592(US11787780, Example 300)
Affinity DataIC50: 4.60nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626566(US11787780, Example 266 | US11787780, Example 296 ...)
Affinity DataIC50: 4.70nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626546(US11787780, Example 237)
Affinity DataIC50: 4.80nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626554(US11787780, Example 250 | US11787780, Example 249)
Affinity DataIC50: 4.80nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626593(US11787780, Example 301)
Affinity DataIC50: 4.80nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626481(US11787780, Example 129)
Affinity DataIC50: 5nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626506(US11787780, Example 160)
Affinity DataIC50: 5nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626526(US11787780, Example 190)
Affinity DataIC50: 5nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626610(US11787780, Example 318)
Affinity DataIC50: 5.10nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626578(US11787780, Example 276)
Affinity DataIC50: 5.40nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626572(US11787780, Example 267)
Affinity DataIC50: 5.60nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626514(US11787780, Example 168)
Affinity DataIC50: 6nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626527(US11787780, Example 191)
Affinity DataIC50: 6nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626585(US11787780, Example 293)
Affinity DataIC50: 6.10nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626551(US11787780, Example 246)
Affinity DataIC50: 6.30nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626587(US11787780, Example 295)
Affinity DataIC50: 6.30nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626580(US11787780, Example 287)
Affinity DataIC50: 6.70nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626607(US11787780, Example 315)
Affinity DataIC50: 6.70nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626566(US11787780, Example 266 | US11787780, Example 296 ...)
Affinity DataIC50: 6.90nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626462(US11787780, Example 108)
Affinity DataIC50: 7nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626485(US11787780, Example 133)
Affinity DataIC50: 7nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626596(US11787780, Example 304)
Affinity DataIC50: 7.5nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626615(US11787780, Example 324)
Affinity DataIC50: 7.5nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626382(US11787780, Example 16 | 5-(3-benzyl-1-(methylsulf...)
Affinity DataIC50: 8nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626385(US11787780, Example 20)
Affinity DataIC50: 8nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626422(US11787780, Example 60)
Affinity DataIC50: 8nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626482(US11787780, Example 130)
Affinity DataIC50: 8nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626513(US11787780, Example 167)
Affinity DataIC50: 8nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626605(US11787780, Example 313)
Affinity DataIC50: 8.30nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626591(US11787780, Example 299)
Affinity DataIC50: 8.80nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626599(US11787780, Example 307)
Affinity DataIC50: 8.80nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626609(US11787780, Example 317)
Affinity DataIC50: 8.90nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626392(US11787780, Example 29 | 1-(1-(4-fluorophenyl)-6-m...)
Affinity DataIC50: 9nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626460(US11787780, Example 106)
Affinity DataIC50: 9nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626520(US11787780, Example 174)
Affinity DataIC50: 9nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626532(US11787780, Example 212)
Affinity DataIC50: 9nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626441(US11787780, Example 84)
Affinity DataIC50: 10nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

TargetGlucocorticoid receptor(Human)
Corcept Therapeutics

US Patent
LigandPNGBDBM626534(US11787780, Example 215)
Affinity DataIC50: 10nMAssay Description:Binding of test compounds to the glucocorticoid receptor (GR) is determined using a fluorescence polarisation (FP) assay utilising a recombinant liga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 262 total ) | Next | Last >>
Jump to: